explore -WSS

explore

author：knowledge 2025-10-01 00:59:55 - browse：43

Without question, the new federal law banning surprise billing is achieving its goal of protecting patients from enormous medical bills. But in doing so, the measure, which was initially projected to lower federal spending, appears to be raising costs elsewhere.

The Biden administration’s new progress report on the process for arbitrating disagreements between insurance companies and providers, which covers the first six months of 2023, shows that in over 80% of payment disputes, the arbiter settled on an amount that was more than the median in-network rate for that service. In other words, insurers were ordered to pay more to an out-of-network provider than they’d pay to a contracted one. Not only that, the sheer volume of disputes means the three federal agencies that run the program are devoting much more time to it than expected.

“It raises concerns for folks that envisioned the arbitration process as helping to moderate costs rather than be a tool these companies can leverage to obtain even higher payments,” said Zachary Baron, the director of Georgetown University’s Health Policy and Law Initiative.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： First Opinion Podcast: What happens when kids become caregivers?

Wikipedia

WSS

Scientists successfully use ultrasound imaging to map brain activity

CDC director unscathed in first congressional testimony

iTeos Therapeutics debuts first data on TIGIT

CDC director unscathed in first congressional testimony

Lab trade group sues FDA to halt regulation of lab

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

focus

explore

knowledge

The high cost of giving birth even with insurance

What don’t we know about an Alzheimer’s drug side effect?

How one medical school became remarkably diverse

The EPA's new lead rule: How one expert crunched the numbers

What does generative AI mean for health care? We asked experts

What to do when lifesaving products contribute to climate change

Psychedelics group wrestles with new pharma identity

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Alkermes shareholders re

Akili, maker of video game for ADHD, to be acquired for 34 million

knowledge

FDA investigates CAR

AI used to predict Covid

David Sabatini, ex

The EPA's new lead rule: How one expert crunched the numbers

Prosthetic arm enables patients to feel the objects they grip

With clinical trial data readouts, here's how to spot spin

focus

hotspot

Wikipedia

focus